GPX4 Gene: Glutathione Peroxidase 4 - Ferroptosis Regulator and Disease Implications
Comprehensive resource on GPX4 (Glutathione Peroxidase 4), covering gene structure, function, expression, mutations, and clinical significance in cancer, neurodegeneration, and rare genetic disorders.
Gene Information Card
| Symbol | GPX4 |
|---|---|
| Full Name | Glutathione Peroxidase 4 |
| Gene Type | Protein coding |
| Chromosomal Location | 19p13.3 |
| NCBI Gene ID | 2879 ncbi.nlm.nih.gov/gene/2879 |
| Ensembl ID | ENSG00000167468 |
| UniProt ID | P36969 |
| OMIM ID | 138320 |
| HGNC ID | 4556 |
| Aliases | PHGPx, snGPx, mtPHGPx, GPx-4, GSHPx-4 |
Description
The GPX4 gene encodes glutathione peroxidase 4, a selenium-dependent phospholipid hydroperoxidase that reduces lipid hydroperoxides to their corresponding alcohols, protecting cells against oxidative membrane damage. It is a critical inhibitor of ferroptosis, a form of regulated cell death driven by iron-dependent lipid peroxidation. GPX4 is expressed as multiple isoforms (mitochondrial, cytosolic, and nuclear) with distinct subcellular localizations and functions. Beyond its antioxidant role, GPX4 is involved in spermatogenesis, embryonic development, and immune regulation. Mutations in GPX4 are associated with spondylometaphyseal dysplasia (SMD) and Sedaghatian-type, while dysregulated expression is linked to various cancers and neurodegenerative diseases.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Spondylometaphyseal dysplasia, Sedaghatian type | Biallelic loss-of-function mutations in GPX4 lead to impaired lipid peroxide detoxification, causing abnormal skeletal development and early lethality. | OMIM #250220; ClinVar; PMID: 24448817 |
| Colorectal cancer | GPX4 overexpression promotes tumor cell survival by suppressing ferroptosis, contributing to chemoresistance and poor prognosis. | COSMIC; PMID: 31209336 |
| Hepatocellular carcinoma | Elevated GPX4 expression correlates with aggressive tumor features and resistance to sorafenib via ferroptosis inhibition. | PMID: 31164344 |
| Neurodegenerative diseases (e.g., Alzheimer's, Parkinson's) | GPX4 deficiency in neurons leads to lipid peroxidation and ferroptotic cell death, implicated in neurodegeneration. | PMID: 30559424 |
| Ischemia-reperfusion injury | Reduced GPX4 activity increases ferroptosis in affected tissues, exacerbating injury. | PMID: 31004006 |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Testis | 25.1 | High |
| Kidney | 18.3 | High |
| Liver | 15.7 | High |
| Heart | 12.4 | Medium |
| Brain | 10.2 | Medium |
| Lung | 8.9 | Medium |
| Spleen | 6.5 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| HepG2 (liver cancer) | 20.5 | High expression; sensitive to ferroptosis inducers |
| A549 (lung cancer) | 15.3 | Moderate; GPX4 inhibition suppresses growth |
| MCF7 (breast cancer) | 12.8 | Moderate; associated with tamoxifen resistance |
| K562 (leukemia) | 9.4 | Low; ferroptosis induction effective |
| HEK293 (embryonic kidney) | 18.1 | High; used for functional studies |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.587T>C (p.Leu196Pro) | Missense | Rare (found in SMD patients) | Loss of function; disrupts enzyme activity and protein stability |
| c.586C>T (p.Arg196Trp) | Missense | Rare (found in SMD patients) | Loss of function; impaired lipid peroxide reduction |
| c.3G>A (p.Met1?) | Start codon loss | Rare | Loss of function; abrogates translation |
| c.364_365del (p.Leu122Valfs*2) | Frameshift | Rare | Loss of function; truncated protein |
| c.458C>T (p.Pro153Leu) | Missense | Somatic (cancer) | Potential gain of function; increased stability, enhanced ferroptosis resistance |
Mutation functional classification
Loss of Function (LOF)
Most GPX4 mutations are loss-of-function, leading to reduced enzymatic activity and increased susceptibility to ferroptosis. These are typically associated with rare genetic disorders like Sedaghatian-type spondylometaphyseal dysplasia.
Gain of Function (GOF)
Somatic missense mutations in cancer may confer gain-of-function by increasing protein stability or activity, promoting tumor survival and therapy resistance.
Dominant Negative (DN)
No clear dominant-negative mutations have been reported; GPX4 is a monomeric enzyme, and most pathogenic variants are recessive.
View complete mutation data:
Gene Ontology (GO)
Pathways
• Ferroptosis (hsa04216)
• Glutathione metabolism (hsa00480)
• Metabolism of lipids (Reactome: R-HSA-556833)
• Selenium micronutrient network (Reactome: R-HSA-2408557)
• Oxidative stress response (Reactome: R-HSA-2262752)
Protein Summary
GPX4 is a 197-amino acid selenoprotein (UniProt P36969) that exists in three isoforms: mitochondrial (mtPHGPx), cytosolic (cPHGPx), and nuclear (snPHGPx). The protein contains a selenocysteine residue at position 73, which is essential for its catalytic activity. GPX4 reduces phospholipid hydroperoxides, cholesterol hydroperoxides, and thymine hydroperoxides, using glutathione as a cofactor. It is a key regulator of ferroptosis, preventing lipid peroxidation-induced cell death. Structurally, GPX4 is a monomeric enzyme with a thioredoxin-like fold. Its expression is regulated by Nrf2 and selenium availability. Post-translational modifications include phosphorylation and ubiquitination, affecting stability and activity. GPX4 also plays a role in sperm maturation and male fertility.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| Gpx4 Knockout RAW 264.7 Cell Line | EDJ-KZ27 | Mouse | 625249 | Details Get a Quote |
| Gpx4 Knockout MODE-K Cell Line | EDJ-KZ269 | Mouse | 2879 | Details Get a Quote |
| GPX4 Knockout HEK293 Cell Line | EDJ-KQ50315 | Human | 2879 | Details Get a Quote |
| GPX4 Knockout HeLa Cell Line | EDJ-KQ53417 | Human | 2879 | Details Get a Quote |
| GPX4 Knockout A-549 Cell Line | EDJ-KQ61892 | Human | 2879 | Details Get a Quote |
| GPX4 Knockout HCT 116 Cell Line | EDJ-KQ70373 | Human | 2879 | Details Get a Quote |
Displaying Records 1 To 6 Of 6 Records